06 / August / 2026 In vivo gene therapies correct mutations within the body A new generation of treatments is using CRISPR, viral vectors, and nanoparticles to modify genes directly inside the body; Brazil is broadening its research efforts in the field Por Daniel Dieb
16 / July / 2026 Can AI help overstretched peer reviewers? Researchers advocate using AI to screen manuscripts, detect fraud, and support editors, while warning of risks to process integrity Por Daniel Dieb
02 / July / 2026 What hinders interdisciplinary researchers Australian study links interdisciplinary careers to temporary contracts, slow career progression, and lower pay Por Daniel Dieb
26 / June / 2026 Europe proposes minimum standards to protect researchers Science Europe report calls for job stability, salary transparency, social security, and better prospects in academia Por Daniel Dieb
25 / June / 2026 Young researchers under growing pressure to remain in science Nature Index survey reveals less autonomy, greater risk of leaving research, and generational differences over impact and open access Por Daniel Dieb
19 / June / 2026 AI shifts from competitive edge to key competence for researchers ResearchComp update highlights the need for researchers across all fields to understand the uses, limitations, and risks of the technology Por Daniel Dieb
17 / June / 2026 Pulmonary fibrosis: AI-developed drug shows promising early results Clinical trial indicates improvement in a measure of lung function, but safety, efficacy, and use with other populations still need to be confirmed Por Daniel Dieb
05 / June / 2026 Predatory journals exploit pressure on Brazilian researchers to publish A study of more than a thousand researchers shows how questionable journals exploit the “publish or perish” culture to attract submissions Por Daniel Dieb
04 / June / 2026 Frontier science takes risk, but Brazil still punishes failure Experts say that truly innovative projects require safer environments in which to make mistakes, recombine knowledge, and challenge paradigms Por Daniel Dieb
02 / June / 2026 Pancreatic cancer: Oral drug almost doubles survival in clinical trial Data presented at ASCO 2026 showed that daraxonrasib reduced the risk of death by 60% in patients with metastatic pancreatic cancer Por Daniel Dieb
